Preliminary results from the "SNAPSHOT study", an NIH-funded collaborative research project between the Division of Sleep and Circadian Disorders at Brigham and Women's Hospital, and...
Preliminary results of a new study show that social jet lag has emerged as an important circadian marker for health outcomes. Results show that social...
A treatment for depression using Emotional Faces Memory Task (EFMT), a technology originally developed by two Mount Sinai researchers, resulted in a significantly greater reduction...
BOSTON -- The National Cancer Institute (NCI) has awarded four Dana-Farber Cancer Institute researchers with Outstanding Investigator Awards (OIA) for ongoing progressive research within their...
Credit: Sullivan Lab, UC Santa Cruz The DNA vital to the life of a cell is packaged in chromosomes, and a variety of checkpoints, repair...
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one...
The immunotherapy drug pembrolizumab--already FDA-approved for other forms of cancer-has been found to be effective in patients with metastatic triple negative breast cancer, according to...
Credit: Penn Medicine CHICAGO -- Six years ago an international team of physician scientists known as BRCA-TAC led a charge to advance clinical testing of...
New Orleans, LA - June 4, 2017 -Research presented at the ASM Microbe 2017 meeting by Bryan Sanchez of California State University-Northridge in Northridge, Calif.,...
ASCO Perspective "Online technologies have transformed communications in practically every aspect of our lives, and now we're seeing they're also allowing patients to take an...
ASCO Perspective "This study provides strong evidence to support adding abiraterone to standard hormone therapy, primarily for men with metastatic prostate cancer," said Sumanta Kumar...
ASCO Perspective "These long-awaited findings show that this new class of treatment can deliver better results for women with BRCA-positive breast cancer," said ASCO President...
ASCO Perspective "Though the study is small and early, it demonstrates compelling evidence that may pave the way for a new class of drugs for...
ASCO Perspective "We continue to see promising reports about possible uses of circulating tumor DNA analysis. While this approach has a ways to go before...
Credit: Brian Strickland/UNC Lineberger CHICAGO-Cancer patients who reported their symptoms to their cancer care providers using a web-based survey lived longer than those patients who...
